Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding

Franco Heidempergher, Antonio Pillan, Vittorio Pinciroli, Fabrizio Vaghi, Claudio Arrigoni, Giorgio Bolis, Carla Caccia, Luciano Dho, Robert McArthur, Mario Varasi

Research output: Contribution to journalArticle

Abstract

A possible bioisosterism between the benzamido and the phenylimidazolidin-2-one moieties has been suggested on the basis of the similarity between the molecular electrostatic potential (MEP) of metoclopramide, a D2 receptor antagonist with weak 5-HT3 receptor antagonist properties, and zetidoline, a D2 receptor antagonist. Starting from this premise, a series of phenylimidazolidin-2-one derivatives bearing a basic azabicycloalkyl or an imidazolylalkyl moiety were synthesized and evaluated for 5-HT3 receptor radioligand binding affinity ([3H]-GR 43694). In vitro 5-HT3 receptor antagonist activity was tested in the guinea pig ileum assay (GPI). A number of high-affinity ligands were shown to be potent 5-HT3 receptor antagonists in vivo as determined by inhibition of the Bezold-Jarisch reflex in the anesthetized rat. In general, the imidazolylalkyl derivatives were found to be more active than azabicycloalkyls. 1-(3,5-Dichlorophenyl)-3-[(5-methyl-1H-imidazol-4- yl)methyl]imidazolidin-2-one (58), in particular, displayed very high affinity for the 5-HT3 receptor (K(i) of 0.038 nM) with a K(b) of 5.62 nM in the GPI assay, being more potent than the reference compounds (ondansetron, tropisetron, granisetron, and BRL 46470) tested. 58 showed an ID50 comparable to that of ondansetron (2.2 μg/kg iv) in the Bezold-Jarisch reflex. A molecular modeling study based on this structurally novel series of compounds allowed the refinement of previously reported 5-HT3 receptor antagonist pharmacophore models.

Original languageEnglish
Pages (from-to)3369-3380
Number of pages12
JournalJournal of Medicinal Chemistry
Volume40
Issue number21
DOIs
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Organic Chemistry

Fingerprint Dive into the research topics of 'Phenylimidazolidin-2-one derivatives as selective 5-HT<sub>3</sub> receptor antagonists and refinement of the pharmacophore model for 5-HT<sub>3</sub> receptor binding'. Together they form a unique fingerprint.

  • Cite this

    Heidempergher, F., Pillan, A., Pinciroli, V., Vaghi, F., Arrigoni, C., Bolis, G., Caccia, C., Dho, L., McArthur, R., & Varasi, M. (1997). Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding. Journal of Medicinal Chemistry, 40(21), 3369-3380. https://doi.org/10.1021/jm970060o